Chao Liu

Chao Liu is a Principal Scientist at Pfizer since April 2022, previously serving as a Senior Scientist. Prior experience includes a Staff Scientist role at City of Hope from August 2015 to April 2022, and postdoctoral positions at the University of Michigan and City of Hope, focusing on DNA damage response and protein post-translational modifications. Chao Liu's expertise encompasses developing assays to investigate RNA-binding functions, collaborating on enzyme inhibitor screenings, and mentoring laboratory staff. Chao Liu holds a PhD in Genetics from Fudan University and a Bachelor's degree in Biotechnology from East China Normal University.